At IVC Evidensia we care every day - for animals, our clients, our colleagues, and for a better environment. We believe a sustainable approach to what we do is who we are.
For an innovative, entrepreneurial company like ours, transforming how we do things to embed sustainability is an exciting challenge. It may not be easy, and we do not have all the answers yet. But it will force us to think differently, and to innovate. Moreover, it will add value, respond to client, employee and investor needs, and support efficiencies in our business.
Our Positive Pawprint strategy is the tool that helps us to do this. Our strategy is based on three pillars, People, Planet and Pets with 15 elements as illustrated below. Our strategy takes us beyond becoming the best veterinary group in the world, to becoming best veterinary group for the world.
The Positive Pawprint
Growing our company as a force for good
Caring for People
Protect and promote the health and wellbeing of our teams
Offer the highest standards of client care and communication
Create welcoming, diverse and inclusive workplaces
Empower clinics to contribute to their local communities
Ensure human rights are respected across our value chain
Caring for Planet
Transition our company toward net-zero climate impact
Minimise our waste footprint through optimal management
Train all clinicians on applied sustainability in veterinary care
We are creating a workplace where we focus on innovation, engagement and teamwork.
Right care, right time, right team
The IVC Evidensia referral network ensures that local teams are empowered to provide exceptional veterinary care by offering all of our patients the right care at the right time, delivered by the right team.
We bring people together to make animal care better. We ensure local teams are empowered to reach their potential through continual investment in our people, our premises and the equipment needed to build the world’s best veterinary group.
A joint veterinary perspective – IVC Evidensia’s veterinary medical board meets with the heads of clinical boards and medical directors from other countries to discuss and agree on quality systems, ethical and clinical policies.